The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Stagg Robert since 2018.
The trader's CIK number is 1735050.
At the time of the last reporting, Stagg Robert was the SVP, Clinical R&D of Oncomed Pharmaceuticals Inc. (stock ticker symbol OMED).
Also see all insider trading activities at Oncomed Pharmaceuticals Inc.
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2018 | OMED | 0 | $0 | 6,664 | $16,300 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2018-10-10 | OMED | Sale | 927 | 2.01 | 1,863 |
| 2018-10-09 | OMED | Sale | 1,686 | 2.13 | 3,589 |
| 2018-04-24 | OMED | Sale | 4,051 | 2.68 | 10,848 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Stagg Robert (SVP, Clinical R&D of Oncomed Pharmaceuticals Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.